Search

Your search keyword '"Kataoka, Kensuke"' showing total 641 results

Search Constraints

Start Over You searched for: Author "Kataoka, Kensuke" Remove constraint Author: "Kataoka, Kensuke"
641 results on '"Kataoka, Kensuke"'

Search Results

1. Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy

2. Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

4. Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis

11. Idiopathic Pulmonary Fibrosis Incidentally Detected by CT Scan as Interstitial Lung Abnormalities

12. Sensitivity of transbronchial lung cryobiopsy in the diagnosis of different interstitial lung diseases

13. Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis

16. Presence of focal usual interstitial pneumonia is a key prognostic factor in progressive pulmonary fibrosis.

19. Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease

21. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease

22. Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan

34. Mohawk promotes the maintenance and regeneration of the outer annulus fibrosus of intervertebral discs.

36. Preclinical idiopathic pulmonary fibrosis (IPF): a retrospective cohort study

37. Early intervention of antifibrotics along with anti-inflammatory treatment in rapidly progressive interstitial lung disease (RP-ILD) with anti-MDA5 antibody-positive dermatomyositis (MDA5-DM)

38. Idiopathic Pulmonary Fibrosis Incidentally Detected by Computed Tomography Scan as Interstitial Lung Abnormalities.

43. Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis

46. Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting

47. A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis

49. Diagnostic significance of secondary bacteremia in patients with COVID-19

50. Physical activity in idiopathic pulmonary fibrosis: Longitudinal change and minimal clinically important difference

Catalog

Books, media, physical & digital resources